Positive for me when compare to FY17 - Net Loss: NZ$4.2m (HY18) vs. NZ$9.6m (FY17) - Revenue: NZ$1.7m (HY18) vs. NZ$2.0m (FY17)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025